Second Question of the Day August 23, 2014 Has anyone else noticed how the compounding pain and scar industy has ramped up advertising recently? Is it because they believed this niche in their industry was endanger? Is it because they are almost daring Congress to pass specific regulatons as to compounding pain and scar medications? Should Congress do just that?

Here is an example of the comments I am seeing over and over in ads and marketing:

Transdermal pain therapy is a 30 billion dollar industry and growing. It is an alternative non-addictive, non-narcotic and non-sedating pain therapy for patients of all ages. Take advantage of this exciting opportunity which offers the highest commissions in the industry through an established pharmacy, compounding with only he highest quality PCCA based formulations.